Please login to the form below
Intra-Cellular Therapeutics
This page shows the latest Intra-Cellular Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Intra-Cellular soars on FDA approval of schizophrenia drug
Shares rocketed following the announcement. US biotech Intra-Cellular Therapeutics has scored approval for its antipsychotic drug Caplyta for the treatment of schizophrenia, to the delight of investors. . ... The approval is an early Christmas present
Latest news
-
Intra-Cellular plans schizophrenia filing in 2018
Says lumateperone could provide additional benefits over existing treatments. US biotech company Intra-Cellular Therapies says it could file its lead drug lumateperone for schizophrenia as early as next year after ... Intra-Cellular maintains this
Intra-Cellular plans schizophrenia filing in 2018
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Former NICE chair Sir Michael Rawlins to lead MHRA
More recently Sir Michael has served on the board of US-based biotech Intra-Cellular Therapeutics.
-
Former NICE chair joins board of biotech
Sir Michael Rawlins joins board of Intra-Cellular Therapeutics. The former chair of England's cost-effectiveness body for medicines, Sir Michael Rawlins, has made a contentious move to the US ... His expertise in the cost-effectiveness of new
Former NICE chair Sir Michael Rawlins to lead MHRA
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Understanding the ‘real world’ starts and ends with the patient
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Sanofi raises profit forecast following positive Q2 results
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- Investors respond positively to “strong” Eli Lilly results
- Sanofi to buy mRNA tech partner, Translate Bio, for $3.2bn
- Novartis to proceed with phase 3 trial for intrathecal OAV-101 in older SMA patients
- Ask the writers: Transitioning from academia to medical writing
- Strategic launch planning: familiar framework, new mindset
- OPEN Health acquires UK medical communications agency Spirit
- The future of office working designed with our people in mind: ‘Work Where You Work Best’, an Evoke KYNE model
- Recruiting patients for real-world studies – the power of a digital campaign
- J&J and Pfizer quietly resolve Remicade biosimilar lawsuit
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- The future of work has been just around the corner for some time...
- Employee wellbeing in creative agencies: three tips to get you started
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Ask the writers: Transitioning from academia to medical writing
- Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
- Strategic launch planning: familiar framework, new mindset
- By James Aird...
- Guide
- How to embrace behavioural science principles in healthcare MR...
